Risk of acute pancreatitis after sitagliptin, a dipeptidyl peptidase - 4 inhibitors

The objective of this study was to assess the risk of acute pancreatitis in patients with type 2 diabetes treated with sitagliptin, a DPP-4 inhibitors.

Source: Pancreatology - June 1, 2018 Category: Gastroenterology Authors: Adriana Gherbon, Romulus Timar Tags: 5. Diabetes and the pancreas Source Type: research